Sign In

Login

Password

Forgot Password ? Sign Up

バルニジピン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "バルニジピン" in Japanese language version.

refsWebsite
Global rank Japanese rank
19nih.gov
4th place
24th place
7doi.org
2nd place
6th place
1pmda.go.jp
6,690th place
394th place
1acs.org
1,248th place
1,765th place
1tandfonline.com
507th place
1,847th place
1medagencies.org
low place
low place

acs.org

pubs.acs.org

  • Tamazawa, K.; H. Arima; T. Kojima; Y. Isomura; M. Okada; S. Fujita; T. Furuya; T. Takenaka; O. Inagaki; M. Terai (12 1986). “Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.”. J Med Chem 29 (12): 2504-11. doi:10.1021/jm00162a013. PMID 3023614. http://pubs.acs.org/doi/abs/10.1021/jm00162a013. 

doi.org

  • Tamazawa, K.; H. Arima; T. Kojima; Y. Isomura; M. Okada; S. Fujita; T. Furuya; T. Takenaka; O. Inagaki; M. Terai (12 1986). “Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.”. J Med Chem 29 (12): 2504-11. doi:10.1021/jm00162a013. PMID 3023614. http://pubs.acs.org/doi/abs/10.1021/jm00162a013. 
  • van Zwieten, PA. (1998). “Pharmacological profile of barnidipine: a single optical isomer dihydropyridine calcium antagonist.”. Blood Press Suppl 1: 5-8. doi:10.1080/080370598438999. PMID 9660520. http://www.tandfonline.com/doi/abs/10.1080/080370598438999?journalCode=iblo20. 
  • Spirou, A.; E. Rizos; EN. Liberopoulos; N. Kolaitis; A. Achimastos; AD. Tselepis; M. Elisaf (12 2006). “Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study.”. J Cardiovasc Pharmacol Ther 11 (4): 256-61. doi:10.1177/1074248406296108. PMID 17220472. 
  • Teramura, T.; T. Watanabe; S. Higuchi; K. Hashimoto (Nov 1995). “Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human.”. Xenobiotica 25 (11): 1237-46. doi:10.3109/00498259509046679. PMID 8592872. 
  • Teramura, T.; Y. Fukunaga; EJ. Van Hoogdalem; T. Watanabe; S. Higuchi (9 1997). “Examination of metabolic pathways and identification of human liver cytochrome P450 isozymes responsible for the metabolism of barnidipine, a calcium channel blocker.”. Xenobiotica 27 (9): 885-900. doi:10.1080/004982597240064. PMID 9381730. 
  • Teramura, T.; T. Watanabe; S. Higuchi; K. Hashimoto (Feb 1997). “Metabolism and pharmacokinetics of barnidipine hydrochloride, a calcium channel blocker, in man following oral administration of its sustained release formulation.”. Xenobiotica 27 (2): 203-16. doi:10.1080/004982597240695. PMID 9058533. 
  • Liau, CS. (Mar 2005). “Barnidipine: a new calcium channel blocker for hypertension treatment.”. Expert Rev Cardiovasc Ther 3 (2): 207-13. doi:10.1586/14779072.3.2.207. PMID 15853594. 

medagencies.org

mri.medagencies.org

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Tamazawa, K.; H. Arima; T. Kojima; Y. Isomura; M. Okada; S. Fujita; T. Furuya; T. Takenaka; O. Inagaki; M. Terai (12 1986). “Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.”. J Med Chem 29 (12): 2504-11. doi:10.1021/jm00162a013. PMID 3023614. http://pubs.acs.org/doi/abs/10.1021/jm00162a013. 
  • van Zwieten, PA. (1998). “Pharmacological profile of barnidipine: a single optical isomer dihydropyridine calcium antagonist.”. Blood Press Suppl 1: 5-8. doi:10.1080/080370598438999. PMID 9660520. http://www.tandfonline.com/doi/abs/10.1080/080370598438999?journalCode=iblo20. 
  • Kuwajima, I.; K. Abe (Feb 2002). “Effects of the long-acting calcium channel blocker barnidipine hydrochloride on 24-h ambulatory blood pressure.”. Blood Press Monit 7 (1): 63-5. PMID 12040247. 
  • Malhotra, HS.; GL. Plosker (2001). “Barnidipine.”. Drugs 61 (7): 989-96; discussion 997-8. PMID 11434453. 
  • Inagaki, O.; M. Asano; T. Takenaka (Feb 1999). “In vitro and in vivo vasodilatory activity of barnidipine and its enantiomers.”. Biol Pharm Bull 22 (2): 151-6. PMID 10077433. 
  • Shimada, S.; Y. Nakajima; K. Yamamoto; Y. Sawada; T. Iga (Mar 1996). “Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients.”. Biol Pharm Bull 19 (3): 430-7. PMID 8924914. 
  • Spirou, A.; E. Rizos; EN. Liberopoulos; N. Kolaitis; A. Achimastos; AD. Tselepis; M. Elisaf (12 2006). “Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study.”. J Cardiovasc Pharmacol Ther 11 (4): 256-61. doi:10.1177/1074248406296108. PMID 17220472. 
  • Teramura, T.; T. Watanabe; S. Higuchi; K. Hashimoto (Nov 1995). “Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human.”. Xenobiotica 25 (11): 1237-46. doi:10.3109/00498259509046679. PMID 8592872. 
  • Teramura, T.; T. Tokunaga; H. Matsumoto; T. Watanabe; S. Higuchi (Feb 1996). “Metabolism of barnidipine hydrochloride, a potent calcium antagonist, in rat and dog.”. Xenobiotica 26 (2): 177-87. PMID 8868001. 
  • Teramura, T.; Y. Fukunaga; EJ. Van Hoogdalem; T. Watanabe; S. Higuchi (9 1997). “Examination of metabolic pathways and identification of human liver cytochrome P450 isozymes responsible for the metabolism of barnidipine, a calcium channel blocker.”. Xenobiotica 27 (9): 885-900. doi:10.1080/004982597240064. PMID 9381730. 
  • Teramura, T.; T. Watanabe; S. Higuchi; K. Hashimoto (Feb 1997). “Metabolism and pharmacokinetics of barnidipine hydrochloride, a calcium channel blocker, in man following oral administration of its sustained release formulation.”. Xenobiotica 27 (2): 203-16. doi:10.1080/004982597240695. PMID 9058533. 
  • Imai, Y.; K. Abe; A. Nishiyama; M. Sekino; K. Yoshinaga (12 1997). “Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24 h, daytime, and nighttime. Barnidipine Study Group.”. Am J Hypertens 10 (12 Pt 1): 1415-9. PMID 9443779. 
  • Spieker, C. (1998). “Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension.”. Blood Press Suppl 1: 15-21. PMID 9660522. 
  • Liau, CS. (Mar 2005). “Barnidipine: a new calcium channel blocker for hypertension treatment.”. Expert Rev Cardiovasc Ther 3 (2): 207-13. doi:10.1586/14779072.3.2.207. PMID 15853594. 
  • Naber, FB.; R. Häge; J. Mortelmans (Nov 2000). “Barnidipine monotherapy and combination therapy in older patients with essential hypertension: a long-term study.”. Int J Clin Pract Suppl (114): 27-35. PMID 11221292. 
  • Otterstad, JE.; LM. Ruilope (Nov 2000). “Treatment of hypertension in the very old.”. Int J Clin Pract Suppl (114): 10-9. PMID 11221289. 
  • Beudeker, HJ.; JW. van der Velden; EM. van der Aar (Nov 2000). “Interaction profile and tolerability of barnidipine.”. Int J Clin Pract Suppl (114): 36-40. PMID 11221293. 
  • Smilde, JG. (Nov 2000). “The long-term efficacy and safety profile of barnidipine.”. Int J Clin Pract Suppl (114): 20-6. PMID 11221291. 
  • van der Velden, JW.; HJ. Beudeker; M. Nishi (1998). “Diversity and intensity of adverse events in the treatment of hypertension with barnidipine.”. Blood Press Suppl 1: 27-9. PMID 9660524. 

pmda.go.jp

info.pmda.go.jp

tandfonline.com